|
|
|
|
2n Personal PCR Testing Platform
|
|
“Hyper-local is the future of healthcare” Point-of-care testing (POCT), such as handheld blood glucose meter, dramatically provides convenience and represents the trend of healthcare. However, POCT MDx is still at its early stage and an ideal POCT MDx platform with low cost and portability is desperately desired but missing. Our proprietary platform, 2n Personal PCR Testing platform, meets the need. It represents the world's first disposable and instrument-free personal PCR testing platform. It has outstanding characteristics of low cost, portability, fast, sensitivity, low power, disposability and more.
~ Intigration of Instrument-Free PCR chip and Visual PCR technology
~ PCR Testing by anyone anywhere
~ Sample-to-result applications across clinic diagonostic, biosecurity, food safety, veterinary and more
|
|
|
Instrument-Free PCR
~ Self-Thermocycling diposable PCR chip
~ Transparent PCR Chip
~ Fast PCR (10-25min)
~ Sensitive PCR (10 copies)
~ Ultra-low cost PCR device
~ low power (12v, 8w)
|
|
|
|
|
|
|
|
Visual PCR
Platform
No DNA extraction, crude sample resistant, sensitive pathogens detection for Point-Of-Care Test (POCT) application. Visually monitor PCR by naked eyes. Has great potential for in-field application of human/animal health, environmental surveillance, water quality, food safety and biodefense. The first research kit is available: Visual-PCR Mycoplasma Detection Kit. |
|
|
Partnerships
The era of personal MDx is coming. Be part of it, join us.
Talented persons with self-motivation and business expertise are highly welcomed.
Far-sighted and distinctive Investors are welcomed to be partners.
Cooperation
Our near-future goal is to launch kits for testing a panel of respiratory diseases and a panel of sexual transmitted diseases. If you want to exploit 2n Personal MDx platform in other applications, such as but not limited to, clinical diseases, veterinary diseases, water/drinking/farm/meat pathogens, transgenic, genotyping, etc., Please contact us.
|
|
|
|
|
|
|